Literature DB >> 28807813

Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis.

Taojun He1, Tracy A McMillen2, Yuanyuan Qiu3, Liang Hua Chen2, Xuedong Lu4, Xiao-Li Pang5, Mini Kamboj6, Yi-Wei Tang7.   

Abstract

In immunocompromised patients with norovirus (NoV) gastroenteritis, the relationship between fecal NoV load and clinical complications has not been examined. In this study, a validated real-time quantitative PCR assay was used to determine viral loads for NoV genogroup I and II (GI and GII) in NoV-positive stool specimens of cancer patients. A total of 234 specimens from 152 patients were positive for NoV, including 201 of GII and 33 of GI. Geometric mean of logarithmic copies per gram of stool (w/w) of NoV-GII were 9.03 ± 1.71 (means ± SD), which was significantly higher than that of NoV-GI [7.87 ± 1.49; odd ratio (OR), 3.22; 95% CI, 1.33-7.76; P = 0.009]. Among 152 patients with gastroenteritis, the fecal NoV geometric mean of logarithmic copy was correlated with mild (n = 85; 7.97 ± 1.55), moderate (n = 23; 9.09 ± 1.38), and severe (n = 44; 10.39 ± 0.91) episodes of severity by modified Vesikari scoring system, respectively. Multivariate analysis revealed that high level of NoV load was correlated with GII infections (OR, 4.13; 95% CI, 1.62-10.55; P = 0.003) and associated with development of severe clinical symptom (OR, 5.53; 95% CI, 2.00-7.24; P = 0.001) at the time of diagnosis. Infection with GII strains was more common than GI infection in cancer patients with viral gastroenteritis.
Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28807813      PMCID: PMC5809680          DOI: 10.1016/j.jmoldx.2017.06.006

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  37 in total

1.  Pre-analytical and analytical procedures for the detection of enteric viruses and enterovirus in water samples.

Authors:  Xiaoli L Pang; Bonita E Lee; Kanti Pabbaraju; Stephan Gabos; Stephen Craik; Pierre Payment; Norman Neumann
Journal:  J Virol Methods       Date:  2012-05-23       Impact factor: 2.014

2.  Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.

Authors:  N Boillat Blanco; R Kuonen; C Bellini; O Manuel; C Estrade; J Mazza-Stalder; J D Aubert; R Sahli; P Meylan
Journal:  Transpl Infect Dis       Date:  2010-08-30       Impact factor: 2.228

3.  Norovirus and severe chronic gastroenteritis in pediatric stem cell transplantation: the plot thickens.

Authors:  Naim Alkhouri; Lara Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2011-07-08

4.  Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis.

Authors:  Naeemah Munir; Pengbo Liu; Paul Gastañaduy; Julia Montes; Andi Shane; Christine Moe
Journal:  J Med Virol       Date:  2013-09-30       Impact factor: 2.327

5.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

Review 6.  Norovirus infection in immunocompromised hosts.

Authors:  K Y Green
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

Review 7.  Norovirus in Transplantation.

Authors:  Michael P Angarone; Anna Sheahan; Mini Kamboj
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

8.  Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG® GPP) testing in the diagnosis of infectious gastroenteritis.

Authors:  E Wessels; L G Rusman; M J A W M van Bussel; E C J Claas
Journal:  Clin Microbiol Infect       Date:  2013-10-17       Impact factor: 8.067

9.  Enhanced enteric virus detection in sporadic gastroenteritis using a multi-target real-time PCR panel: a one-year study.

Authors:  Xiaoli L Pang; Jutta K Preiksaitis; Bonita E Lee
Journal:  J Med Virol       Date:  2013-11-14       Impact factor: 2.327

10.  Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding.

Authors:  K L Newman; C L Moe; A E Kirby; W D Flanders; C A Parkos; J S Leon
Journal:  Clin Exp Immunol       Date:  2016-02-25       Impact factor: 4.330

View more
  3 in total

1.  Norovirus outbreaks in long-term care facilities in Catalonia from 2017 to 2018.

Authors:  Ignacio Parrón; Irene Barrabeig; Miquel Alseda; Cristina Rius; Thais Cornejo-Sánchez; Mireia Jané; Cristina Pérez; Susana Guix; Àngela Domínguez
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

2.  Clinical significance and intestinal microbiota composition in immunocompromised children with norovirus gastroenteritis.

Authors:  Pei-Chun Lin; Yu-Chen S H Yang; Sheng-Chieh Lin; Meng-Che Lu; Yin-Tai Tsai; Shou-Cheng Lu; Shu-Huey Chen; Shih-Yen Chen
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

Review 3.  Norovirus in Cancer Patients: A Review.

Authors:  Divya Samantha Kondapi; Sasirekha Ramani; Mary K Estes; Robert L Atmar; Pablo C Okhuysen
Journal:  Open Forum Infect Dis       Date:  2021-03-14       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.